Results 31 to 40 of about 65,657 (193)

Effects of cytomegalovirus infection on the differential diagnosis between biliary atresia and intrahepatic cholestasis in a Chinese large cohort study

open access: yesAnnals of Hepatology, 2021
Introduction and objectives: Differentiating biliary atresia from other causes of neonatal cholestasis is challenging, particularly when cytomegalovirus (CMV) and biliary atresia occur simultaneously.
Dongying Zhao   +6 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Benign Recurrent Intrahepatic Cholestasis in Pregnancy: Fetal Death at 36 Weeks of Gestation

open access: yesCase Reports in Obstetrics and Gynecology, 2021
Introduction. Benign recurrent intrahepatic cholestasis is a rare hepatologic disorder characterized by recurrent, self-limited episodes of severe pruritus, jaundice, and elevated bile acids.
Mariam Ayyash   +4 more
doaj   +1 more source

Plasma lipid profiles of women with intrahepatic cholestasis of pregnancy

open access: yes, 2006
OBJECTIVE: Intrahepatic cholestasis of pregnancy is associated with dyslipidemia, but the gestational lipid profile in relation to clinical diagnosis of the disease is unknown.
Seed, P T   +5 more
core   +6 more sources

Evaluation of Plasma Lipid Levels in Intrahepatic Cholestasis of Pregnancy

open access: yesHitit Medical Journal, 2023
Objective: To investigate the total cholesterol, triglyceride, LDL, VLDL, and HDL levels of pregnant women diagnosed with intrahepatic cholestasis of pregnancy and to examine the association with disease severity.
Şevki Çelen   +2 more
doaj   +1 more source

Prevalence and Pregnancy Outcomes of Intrahepatic Cholestasis of Pregnancy

open access: yesJournal of Nepal Health Research Council, 2021
Background: Intrahepatic cholestasis of pregnancy is a common pregnancy-specific liver disease associated with increased risk of adverse fetal and maternal outcomes. We sought to determine its prevalence, risk factors and feto-maternal outcomes. Methods:
Deekshanta Sitaula   +4 more
doaj   +1 more source

Da-Chai-Hu-Tang Protects From Acute Intrahepatic Cholestasis by Inhibiting Hepatic Inflammation and Bile Accumulation via Activation of PPARα

open access: yesFrontiers in Pharmacology, 2022
Cholestasis is caused by intrahepatic retention of excessive toxic bile acids and ultimately results in hepatic failure. Da-Chai-Hu-Tang (DCHT) has been used in China to treat liver and gallbladder diseases for over 1800 years. Here, we demonstrated that
Shihao Xu   +16 more
doaj   +1 more source

Dengue fever as a potential cause of sickle cell intrahepatic cholestasis: A report of two cases

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2021
Sickle cell intrahepatic cholestasis is a potentially fatal syndrome characterized by jaundice, painful hepatomegaly, and organ dysfunction. Two cases of sickle cell intrahepatic cholestasis associated with dengue fever were described. Endothelial damage/
Leonardo Rodrigues de Oliveira   +5 more
doaj   +1 more source

The non-HDL-C to APOB ratio as a predictor of inaccurate LDL-C measurement in patients with chronic intrahepatic cholestasis and jaundice: a retrospective study [PDF]

open access: yesPeerJ
Background Cholestasis is characterized by the accumulation of bile in the liver or biliary system due to obstruction or impaired flow, necessitating lipid profiling to assess lipid metabolism abnormalities.
Yongjiang Cheng   +3 more
doaj   +2 more sources

Compound Heterozygous MYO5B Mutation, a Cause of Infantile Cholestasis: A Case Report

open access: yesJournal of Nepal Medical Association, 2022
Infantile cholestasis is a common clinical problem in early infancy characterised by impairment in bile formation and/or flow. It requires prompt evaluation for underlying aetiology to initiate appropriate management.
Muna Khanal   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy